Garheng Kong

(Dr. Garheng Kong M.D., PH.D.)

Currently holds positions in Alimera Sciences Inc, Laboratory Corporation of America Holdings and Strongbridge Biopharma plc

Positions

Position Company Period
Independent Director Alimera Sciences Inc Oct. 1, 2012 -
Independent Director Laboratory Corporation of America Holdings Dec. 1, 2013 -
Lead Independent Director Strongbridge Biopharma plc Nov. 18, 2019 -
Independent Director Melinta Therapeutics Inc Jan. 1, 2016 - June 11, 2019
Independent Chairman of the Board Ocugen Inc July 1, 2012 - Feb. 22, 2019
Independent Chairman of the Board Melinta Therapeutics Inc Nov. 1, 2008 - Jan. 1, 2016
Garheng Kong's trades of Venus Concept Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-17 2021-12-15
B Purchase
1,600,000 +30.8%
1.25
USD 2,000,000 		1,600,000 +30.8% 1.25 USD 2,000,000
2019-02-19 2019-02-19
US Avedro Inc (AVDR)
B Purchase
142,857 +11.0%
14.00
USD 1,999,998 		142,857 +11.0% 14.00 USD 1,999,998
// ... existing code ... // ... rest of the file ...